A protein replacement therapy may rescue the brain from Alzheimer's, so says a UC researcher whose new study was published Monday. Professor of Neurology Alberto Espay is frustrated the FDA recently ...

The study finds it's not the plaques that need to be treated but the loss of a protein in the brain The study finds it's not the plaques that need to be treated but the loss of a protein in the brain ...

The University of Cincinnati’s Alberto Espay, MD, will present Parkinson’s disease research at the American Academy of Neurology’s annual meeting, April 22-27, in Boston, Massachusetts, and online.

The Alzheimer’s disease (AD) drug lecanemab’s recent success in Biogen’s Phase III clinical trials might have more to do with its effect in increasing levels of soluble amyloid-beta than in decreasing ...

Please provide your email address to receive an email when new articles are posted on . A study of more than 1,000 patients with Parkinson’s disease dementia found that patients who also had ...